WST — WEST PHARMACEUTICAL SERVICES INC

NYSE · Health Care · Health Care Equipment & Supplies · CIK 105770 ·
Last close
$323.59
Market Cap
$22.86B
52W High
$336.82
52W Low
$234.40
ADV30
739,766
Next earnings
2026-07-23
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 844,900,000 296,400,000 181,100,000 138,800,000 4,109,800,000 521,400,000 1,119,400,000
Dec 2025 805,000,000 303,900,000 175,100,000 132,100,000 4,270,000,000 791,300,000 1,094,000,000
Sep 2025 804,600,000 294,300,000 174,500,000 140,000,000 4,105,800,000 628,500,000 1,054,300,000
Jun 2025 766,500,000 273,900,000 158,900,000 131,800,000 3,952,800,000 509,700,000 1,023,700,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$715,300,000
Investing CF
$-257,300,000
Financing CF
$-346,800,000
CapEx
$-257,300,000
Dividends Paid
$-61,800,000
Buybacks
$-300,900,000
EPS Diluted TTM
$7.48
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$4,475,900,000
Inventory
$452,600,000
Receivables
$685,600,000
ST Investments
EBIT TTM
$672,500,000
Pretax Income TTM
$670,500,000
Interest Exp TTM
$2,000,000
Analysts
13

Yahoo Snapshot (yfinance, live)

Total Revenue
$3,220,999,936
EBITDA
$869,900,032
Free Cash Flow
$275,662,496
Enterprise Value
$23,083,634,688
Total Cash
$521,400,000
Total Debt
$321,000,000
Shares Out
70,647,595
Trailing EPS
$7.48
Book Value
$42.18
ROE
19.1%
ROA
11.2%
Div Yield
0.27%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 3,074,100,000 636,100,000 493,700,000 4,270,000,000 1,094,000,000 754,800,000
Dec 2024 2,893,200,000 590,900,000 492,700,000 3,643,400,000 961,100,000 653,400,000
Dec 2023 2,949,800,000 707,400,000 593,400,000 3,829,500,000 948,500,000 776,500,000
Dec 2022 2,886,900,000 760,800,000 585,900,000 3,616,800,000 931,900,000 724,000,000

TTM Snapshot

Revenues TTM
$2,887,700,000
NetIncome TTM
$593,500,000
OpCashFlow TTM
$0
Assets (Latest)
$3,643,400,000
Forward EPS
$9.56

Max Pain — expiry 2027-12-17 (volume-derived — Yahoo OI feed degraded)

max pain strike: $280.00 · spot: $323.59 · call volume: 169 · put volume: 2
Expected Move to 2027-12-17: ±$124.50 (38.47%) — implied range $199.09$448.09 · ATM straddle on $320.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
RYLPF KONINKLIJKE PHILIPS NV $25.08B $25.81
FSNUY Fresenius SE & Co. KGaA $25.19B $11.18
PHG KONINKLIJKE PHILIPS NV $25.50B $26.24
STE STERIS plc $19.43B $199.40
RMD RESMED INC $27.02B $186.29

News headlines (Yahoo Finance, 1h cache)

Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
2026-06-17 15:16 · Yahoo
LivaNova Reports Improved OSA Outcomes With PolySync Programming
2026-06-17 14:14 · Yahoo
Reasons to Retain Baxter International Stock in Your Portfolio for Now
2026-06-16 18:14 · Yahoo
InspireMD Posts Positive CGUARDIANS II Data for CGuard Prime TCAR
2026-06-16 16:41 · Yahoo
DXCM Receives FDA Clearance for Stelo OTC CGM System for Children
2026-06-16 13:55 · Yahoo
Here's Why You Should Retain BDX Stock in Your Portfolio Now
2026-06-16 13:54 · Yahoo
How Investors May Respond To West Pharmaceutical Services (WST) Upgraded 2026 Outlook And Biologics Momentum
2026-06-16 01:09 · Yahoo
QIAGEN Expands QIAcuity Gene Expression Portfolio to Drive dPCR Use
2026-06-15 15:16 · Yahoo
GEHC Expands Carilion Tie to Enhance Patient Care Across Virginia
2026-06-15 14:50 · Yahoo
Is West Pharmaceutical Stock Outperforming the S&P 500?
2026-06-15 06:55 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.